These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6806458)

  • 1. The effect of acetylsalicylic acid on serum free valproate concentrations and valproate clearance in children.
    Farrell K; Orr JM; Abbott FS; Ferguson S; Sheppard I; Godolphin W; Bruni J
    J Pediatr; 1982 Jul; 101(1):142-4. PubMed ID: 6806458
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-related pharmacokinetics and pharmacodynamics of valproate in the elderly.
    Felix S; Sproule BA; Hardy BG; Naranjo CA
    J Clin Psychopharmacol; 2003 Oct; 23(5):471-8. PubMed ID: 14520124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical valproate toxicity induced by acetylsalicylic acid.
    Goulden KJ; Dooley JM; Camfield PR; Fraser AD
    Neurology; 1987 Aug; 37(8):1392-4. PubMed ID: 3112611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of unbound clearance on binding parameters of valproic acid to serum proteins.
    Kodama Y; Tsutsumi K; Teraoka I; Fujii I; Takeyama M
    J Clin Pharmacol; 1993 Feb; 33(2):130-5. PubMed ID: 8440760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid toxicity associated with low dose of aspirin and low total valproic acid levels: a case report.
    de Leon J; Kiesel JL; Fleming MW; Strobl B
    J Clin Psychopharmacol; 2009 Oct; 29(5):509-11. PubMed ID: 19745660
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproate levels in children with epilepsy.
    Minns RA; Brown JK; Blackwood DH; McQueen JK
    Lancet; 1982 Mar; 1(8273):677-8. PubMed ID: 6121982
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of sodium valproate in dog and mouse.
    Löscher W; Esenwein H
    Arzneimittelforschung; 1978; 28(5):782-7. PubMed ID: 373773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation among sodium valproate concentrations in the total blood, plasma ultrafiltrate, and cerebrospinal fluid].
    Murata Y; Irimichi H; Okamoto M; Hirose K; Hayashi R; Miyamaru N
    No To Hattatsu; 1983 Sep; 15(5):390-5. PubMed ID: 6419752
    [No Abstract]   [Full Text] [Related]  

  • 9. Valproic acid pharmacokinetics in children. IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance.
    Cloyd JC; Fischer JH; Kriel RL; Kraus DM
    Clin Pharmacol Ther; 1993 Jan; 53(1):22-9. PubMed ID: 8422737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of sodium valproate in epileptic patients: prediction of maintenance dosage by single-dose study.
    Schapel GJ; Beran RG; Doecke CJ; O'Reilly WJ; Reece PA; Rischbieth RH; Sansom LN; Stanley PE
    Eur J Clin Pharmacol; 1980 Jan; 17(1):71-7. PubMed ID: 6768573
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of aspirin on valproic acid metabolism.
    Abbott FS; Kassam J; Orr JM; Farrell K
    Clin Pharmacol Ther; 1986 Jul; 40(1):94-100. PubMed ID: 3087680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between valproic acid and aspirin in epileptic children: serum protein binding and metabolic effects.
    Orr JM; Abbott FS; Farrell K; Ferguson S; Sheppard I; Godolphin W
    Clin Pharmacol Ther; 1982 May; 31(5):642-9. PubMed ID: 6804150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in level-dose ratio of valproate: monotherapy versus polytherapy.
    Levy RH
    Epilepsia; 1984; 25 Suppl 1():S10-3. PubMed ID: 6425042
    [No Abstract]   [Full Text] [Related]  

  • 14. Free sodium valproate monitoring.
    Roman EJ; Ponniah P; Lambert JB; Buchanan N
    Br J Clin Pharmacol; 1982 Mar; 13(3):452-5. PubMed ID: 6800393
    [No Abstract]   [Full Text] [Related]  

  • 15. Valproate metabolite concentrations in brain increase with chronic administration of sodium valproate.
    Carl GF; DeLoach C; Patterson J
    Life Sci; 1985 Nov; 37(21):2029-35. PubMed ID: 3934486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of UGT1A6 genetic polymorphisms on the metabolism of sodium valproate].
    Sun YP; Tan L; Wang Y; Song JH
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(29):2033-5. PubMed ID: 17925173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of status epilepticus in children with rectal sodium valproate.
    Snead OC; Miles MV
    J Pediatr; 1985 Feb; 106(2):323-5. PubMed ID: 3918159
    [No Abstract]   [Full Text] [Related]  

  • 18. Intra-dose variation in plasma protein binding of sodium valproate in epileptic patients.
    Marty JJ; Kilpatrick CJ; Moulds RF
    Br J Clin Pharmacol; 1982 Sep; 14(3):399-404. PubMed ID: 6812608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioavailability of sodium valproate.
    Klotz U; Antonin KH
    Clin Pharmacol Ther; 1977 Jun; 21(6):736-43. PubMed ID: 324695
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of age, body weight and dose on sodium valproate plasma concentrations in children with epilepsy].
    Jiang Z; Zhang J; Liao HM; Tang JW; Peng QL
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):325-8. PubMed ID: 18554460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.